Febrile Seizure Risk Factors and Clinical Management

Febrile seizures are convulsive events occurring in young children aged approximately six months to five years in association with fever, absent intracranial infection or metabolic disturbance. They affect around 2–5 per cent of this age group worldwide and are subdivided into simple febrile seizures, which are brief, generalised and occur once in a 24-hour period, and complex febrile seizures, which are prolonged, focal or recurrent. Key risk factors include a rapid rise in body temperature, high peak fever, family history of febrile seizures or epilepsy, neonatal complications and certain micronutrient deficiencies such as iron and magnesium. Viral infections, particularly of the respiratory tract, frequently precipitate febrile episodes, while immunisation has a low but measurable association when seizures occur within days of vaccine administration. Although the majority of children experience a benign course with an excellent prognosis, repeated or complex events may warrant closer neurodevelopmental surveillance. Clinical management revolves around prompt assessment to exclude serious causes, symptomatic fever control, guidance on emergency anticonvulsant use (for example buccal midazolam) and clear parental education to alleviate anxiety. Prophylactic antipyretics do not prevent recurrence but maintaining hydration and treating underlying infection remain central. Current guidelines advocate minimal invasive investigations for simple presentations, reserving neuroimaging and electroencephalography for atypical or complex cases.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Febrile Seizure Risk Factors and Clinical Management publication trend

The graph below shows the total number of articles in febrile seizure risk factors and clinical management across all publications each year (not limited to Nature Index journals).

Technical terms

Simple febrile seizure: A brief, generalised convulsion lasting less than 15 minutes and not recurring within 24 hours in a febrile child without focal neurological signs.

Complex febrile seizure: A convulsion associated with fever that is focal, prolonged (over 15 minutes) or recurs within 24 hours, requiring further investigation.

GABAergic dysregulation: Imbalance in inhibitory neurotransmission mediated by gamma-aminobutyric acid, which can lower seizure threshold.

Blood–brain barrier permeability: Degree to which inflammatory or infectious agents can pass from the bloodstream into the central nervous system, influencing seizure risk.

References

1. The long-term neurodevelopmental outcomes of febrile seizures and underlying mechanisms. Frontiers in Cell and Developmental Biology (2023).
2. Management of Pediatric Febrile Seizures. International Journal of Environmental Research and Public Health (2018).
3. A Review of Febrile Seizures: Recent Advances in Understanding of Febrile Seizure Pathophysiology and Commonly Implicated Viral Triggers. Frontiers in Pediatrics (2022).
4. An observational study of febrile seizures: the importance of viral infection and immunization. BMC Pediatrics (2016).
5. The Relationship between Iron Deficiency and Febrile Convulsion: A Case-Control Study. Global Journal of Health Science (2015).
6. Risk of low serum levels of ionized magnesium in children with febrile seizure. BMC Pediatrics (2018).
7. Febrile Seizures and Respiratory Viruses Determined by Multiplex Polymerase Chain Reaction Test and Clinical Diagnosis. Children (2020).